Showing results (61-70 of 388) with videos related to
Sort By:
Pageof 39
Current Medicinal Chemistry|January 21, 2014
Recent progress in the research of small molecule HIV-1 RNase H inhibitorsLili Cao, Weiguo Song, Erik De Clercq, et al.Current Medicinal Chemistry|November 30, 2010
Functional roles of azoles motif in anti-HIV agentsPeng Zhan, Dongyue Li, Xuwang Chen, et al.Bioorganic & Medicinal Chemistry|August 4, 2009
1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluationPeng Zhan, Xinyong Liu, Zengjun Fang, et al.Current Medicinal Chemistry|May 17, 2011
Retroviral restriction factors TRIM5α: therapeutic strategy to inhibit HIV-1 replicationJing Zhang, Weiying Ge, Peng Zhan, et al.Current Medicinal Chemistry|January 17, 2017
Update on Recent Developments in Small Molecular HIV-1 RNase H Inhibitors (2013-2016): Opportunities and ChallengesXueshun Wang, Ping Gao, Luis Menendez-Arias, et al.Current Medicinal Chemistry|January 22, 2010
TSG101: a novel anti-HIV-1 drug targetHongfei Chen, Xinyong Liu, Zhenyu Li, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 1, 2024
Target-based drug design strategies to overcome resistance to antiviral agents: opportunities and challengesShaoqing Du, Xueping Hu, Luis Menéndez-Arias, et al.Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Synthesis of the novel liqustrazine derivatives and Their protective effect on injured vascular endothelial cell damaged by hydrogen peroxideXinyong Liu, Rui Zhang, Wenfang Xu, et al.Expert Opinion on Therapeutic Patents|October 15, 2014
Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011-2014)Xiao Li, Lingzi Zhang, Ye Tian, et al.Expert Opinion on Drug Discovery|July 12, 2016
Discovery of novel anti-HIV agents via Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry-based approachPing Gao, Lin Sun, Junsu Zhou, et al.Pageof 39